An autotransporter display platform for the development of multivalent recombinant bacterial vector vaccines

Microbial Cell Factories

Volumn 13, Issue 1, 2014, Pages

  Jong, Wouter S P ^a,b   Daleke Schermerhorn, Maria H ^a,b   Vikstrom, David ^c,d   ten Hagen Jongman, Corinne M ^a,b   de Punder, Karin ^e,h   van der Wel, Nicole N ^e,i   van de Sandt, Carolien E ^f   Rimmelzwaan, Guus F ^f   Follmann, Frank ^g   Agger, Else Marie ^g   Andersen, Peter ^g   de Gier, Jan Willem ^c,d   Luirink, Joen ^a,b  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b Abera Bioscience AB   (Sweden)

^c Xbrane Bioscience   (Sweden)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g STATENS SERUM INSTITUT   (Denmark)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Antigen delivery; Autotransporter; Multivalent; Recombinant live vaccine; Surface display

Indexed keywords

AG85B ANTIGEN; BACTERIAL VECTOR; CARRIER PROTEIN; EARLY SECRETORY ANTIGENIC TARGET 6; HEMOGLOBIN PROTEASE; MYCOBACTERIUM ANTIGEN; RECOMBINANT ANTIGEN; RV2660C ANTIGEN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL SECRETION SYSTEM; BACTERIAL VACCINE; HEMOGLOBIN PROTEASE HBP; INFLUENZA VACCINE; PROTEINASE; VIRUS ANTIGEN;

ARTICLE; BACTERIAL CHROMOSOME; CELL SURFACE DISPLAY; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; ESCHERICHIA COLI; INFLUENZA A VIRUS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; TYPE V SECRETION SYSTEM; TYPE VA SECRETION SYSTEM; BACTERIAL SECRETION SYSTEM; GENETICS; METABOLISM;

ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; BACTERIAL SECRETION SYSTEMS; BACTERIAL VACCINES; CHLAMYDIA TRACHOMATIS; ENDOPEPTIDASES; ESCHERICHIA COLI; INFLUENZA A VIRUS; INFLUENZA VACCINES; MYCOBACTERIUM TUBERCULOSIS; SALMONELLA TYPHIMURIUM;

EID: 84964315819     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/s12934-014-0162-8     Document Type: Article

References (72)

1. Moreno M, Kramer MG, Yim L, Chabalgoity JA: Salmonella as live trojan horse for vaccine development and cancer gene therapy. Curr Gene Ther 2010, 10:56-76.
2. Hess J, Gentschev I, Miko D, Welzel M, Ladel C, Goebel W, Kaufmann SH: Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc Natl Acad Sci U S A 1996, 93:1458-1463.
3. Kang HY, Curtiss R 3rd: Immune responses dependent on antigen location in recombinant attenuated Salmonella typhimurium vaccines following oral immunization. FEMS Immunol Med Microbiol 2003, 37:99-104.
4. van Ulsen P, Rahman SU, Jong WS, Daleke-Schermerhorn MH, Luirink J: Type V secretion: From biogenesis to biotechnology. Biochim Biophys Acta 2014, 1843:1592-1611.
5. Grijpstra J, Arenas J, Rutten L, Tommassen J: Autotransporter secretion: varying on a theme. Res Microbiol 2013, 164:562-582.
6. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala'Aldeen D: Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol Rev 2004, 68:692-744.
7. Pohlner J, Halter R, Beyreuther K, Meyer TF: Gene structure and extracellular secretion of Neisseria gonorrhoeae IgA protease. Nature 1987, 325:458-462.
8. Ieva R, Bernstein HD: Interaction of an autotransporter passenger domain with BamA during its translocation across the bacterial outer membrane. Proc Natl Acad Sci U S A 2009, 106:19120-19125.
9. Sauri A, Ten Hagen-Jongman CM, van Ulsen P, Luirink J: Estimating the size of the active translocation pore of an autotransporter. J Mol Biol 2012, 416:335-345.
10. Jose J, Meyer TF: The autodisplay story, from discovery to biotechnical and biomedical applications. Microbiol Mol Biol Rev 2007, 71:600-619.
11. Jong WS, Sauri A, Luirink J: Extracellular production of recombinant proteins using bacterial autotransporters. Curr Opin Biotechnol 2010, 21:646-652.
12. Buddenborg C, Daudel D, Liebrecht S, Greune L, Humberg V, Schmidt MA: Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier. Int J Med Microbiol 2008, 298:105-114.
13. Castillo Alvarez AM, Vaquero-Vera A, Fonseca-Linan R, Ruiz-Perez F, Villegas-Sepulveda N, Ortega-Pierres G: A prime-boost vaccination of mice with attenuated Salmonella expressing a 30-mer peptide from the Trichinella spiralis gp43 antigen. Vet Parasitol 2013, 194:202-206.
14. Chen H, Schifferli DM: Comparison of a fimbrial versus an autotransporter display system for viral epitopes on an attenuated Salmonella vaccine vector. Vaccine 2007, 25:1626-1633.
15. Jong WS, Soprova Z, de Punder K, ten Hagen-Jongman CM, Wagner S, Wickstrom D, de Gier JW, Andersen P, van der Wel NN, Luirink J: A structurally informed autotransporter platform for efficient heterologous protein secretion and display. Microb Cell Fact 2012, 11:85.
16. Kjaergaard K, Hasman H, Schembri MA, Klemm P: Antigen 43-mediated autotransporter display, a versatile bacterial cell surface presentation system. J Bacteriol 2002, 184:4197-4204.
17. Kramer U, Rizos K, Apfel H, Autenrieth IB, Lattemann CT: Autodisplay: development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains. Infect Immun 2003, 71:1944-1952.
18. Rizos K, Lattemann CT, Bumann D, Meyer TF, Aebischer T: Autodisplay: efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains. Infect Immun 2003, 71:6320-6328.
19. Ruiz-Olvera P, Ruiz-Perez F, Sepulveda NV, Santiago-Machuca A, Maldonado-Rodriguez R, Garcia-Elorriaga G, Gonzalez-Bonilla C: Display and release of the Plasmodium falciparum circumsporozoite protein using the autotransporter MisL of Salmonella enterica. Plasmid 2003, 50:12-27.
20. Ruiz-Perez F, Leon-Kempis R, Santiago-Machuca A, Ortega-Pierres G, Barry E, Levine M, Gonzalez-Bonilla C: Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL. Infect Immun 2002, 70:3611-3620.
21. Schroeder J, Aebischer T: Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses. Vaccine 2009, 27:6748-6754.
22. Sevastsyanovich YR, Leyton DL, Wells TJ, Wardius CA, Tveen-Jensen K, Morris FC, Knowles TJ, Cunningham AF, Cole JA, Henderson IR: A generalised module for the selective extracellular accumulation of recombinant proteins. Microb Cell Fact 2012, 11:69.
23. Van Gerven N, Sleutel M, Deboeck F, De Greve H, Hernalsteens JP: Surface display of the receptor-binding domain of the F17a-G fimbrial adhesin through the autotransporter AIDA-I leads to permeability of bacterial cells. Microbiology 2009, 155:468-476.
24. Zhang J, De Masi L, John B, Chen W, Schifferli DM: Improved delivery of the OVA-CD4 peptide to T helper cells by polymeric surface display on Salmonella. Microb Cell Fact 2014, 13:80.
25. Otto BR, Sijbrandi R, Luirink J, Oudega B, Heddle JG, Mizutani K, Park SY, Tame JR: Crystal structure of hemoglobin protease, a heme binding autotransporter protein from pathogenic Escherichia coli. J Biol Chem 2005, 280:17339-17345.
26. Braselmann E, Clark PL: Autotransporters: The Cellular Environment Reshapes a Folding Mechanism to Promote Protein Transport. J Phys Chem Lett 2012, 3:1063-1071.
27. Tajima N, Kawai F, Park SY, Tame JR: A novel intein-like autoproteolytic mechanism in autotransporter proteins. J Mol Biol 2010, 402:645-656.
28. Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, Dolganov G, Schoolnik GK, Cassidy JP, Billeskov R, Andersen P: A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 2011, 17:189-194.
29. Daleke-Schermerhorn MH, Felix T, Soprova Z, Ten Hagen-Jongman CM, Vikstrom D, Majlessi L, Beskers J, Follmann F, de Punder K, van der Wel NN, Baumgarten T, Pham TV, Piersma SR, Jiménez CR, van Ulsen P, de Gier JW, Leclerc C, Jong WS, Luirink J: Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach. Appl Environ Microbiol 2014, 80:5854-5865.
30. Collins BS: Gram-negative outer membrane vesicles in vaccine development. Discov Med 2011, 12:7-15.
31. Lubitz P, Mayr UB, Lubitz W: Applications of bacterial ghosts in biomedicine. Adv Exp Med Biol 2009, 655:159-170.
32. Dietrich J, Weldingh K, Andersen P: Prospects for a novel vaccine against tuberculosis. Vet Microbiol 2006, 112:163-169.
33. Renshaw PS, Lightbody KL, Veverka V, Muskett FW, Kelly G, Frenkiel TA, Gordon SV, Hewinson RG, Burke B, Norman J, Williamson RA, Carr MD: Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J 2005, 24:2491-2498.
34. Anderson DH, Harth G, Horwitz MA, Eisenberg D: An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase. J Mol Biol 2001, 307:671-681.
35. Jong WS, ten Hagen-Jongman CM, den Blaauwen T, Slotboom DJ, Tame JR, Wickstrom D, de Gier JW, Otto BR, Luirink J: Limited tolerance towards folded elements during secretion of the autotransporter Hbp. Mol Microbiol 2007, 63:1524-1536.
36. Dautin N, Barnard TJ, Anderson DE, Bernstein HD: Cleavage of a bacterial autotransporter by an evolutionarily convergent autocatalytic mechanism. EMBO J 2007, 26:1942-1952.
37. Drowart A, De Bruyn J, Huygen K, Damiani G, Godfrey HP, Stelandre M, Yernault JC, Van Vooren JP: Isoelectrophoretic characterization of protein antigens present in mycobacterial culture filtrates and recognized by monoclonal antibodies directed against the Mycobacterium bovis BCG antigen 85 complex. Scand J Immunol 1992, 36:697-702.
38. Kalupahana R, Emilianus AR, Maskell D, Blacklaws B: Salmonella enterica serovar Typhimurium expressing mutant lipid A with decreased endotoxicity causes maturation of murine dendritic cells. Infect Immun 2003, 71:6132-6140.
39. Bachmann BJ: Derivations and genotypes of some mutant derivatives of Escherichia coli K-12. In Escherichia coli and Salmonella Typhimurium: Cellular and Molecular Biology, Volume 2. Edited by Neidhardt FC, Ingraham JL, Low KB, Magasanik B, Schaechter M, Umbarger HE. Washington, DC: American Society for Microbiology; 1987:1190-1219.
40. Kim SK, DeMars R: Epitope clusters in the major outer membrane protein of Chlamydia trachomatis. Curr Opin Immunol 2001, 13:429-436.
41. Cristobal S, Scotti P, Luirink J, von Heijne G, de Gier JW: The signal recognition particle-targeting pathway does not necessarily deliver proteins to the sec-translocase in Escherichia coli. J Biol Chem 1999, 274:20068-20070.
42. Wilson IA, Skehel JJ, Wiley DC: Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981, 289:366-373.
43. Neirynck S, Deroo T, Saelens X, Vanlandschoot P, Jou WM, Fiers W: A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med 1999, 5:1157-1163.
44. Belz GT, Xie W, Altman JD, Doherty PC: A previously unrecognized H-2D (b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge. J Virol 2000, 74:3486-3493.
45. Rimmelzwaan GF, Fouchier RA, Osterhaus AD: Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. Curr Opin Biotechnol 2007, 18:529-536.
46. van Bloois E, Winter RT, Kolmar H, Fraaije MW: Decorating microbes: surface display of proteins on Escherichia coli. Trends Biotechnol 2011, 29:79-86.
47. Ni Y, Chen R: Extracellular recombinant protein production from Escherichia coli. Biotechnol Lett 2009, 31:1661-1670.
48. Olsen AW, Williams A, Okkels LM, Hatch G, Andersen P: Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model. Infect Immun 2004, 72:6148-6150.
49. Olsen AW, van Pinxteren LA, Okkels LM, Rasmussen PB, Andersen P: Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6. Infect Immun 2001, 69:2773-2778.
50. Maas C, Hermeling S, Bouma B, Jiskoot W, Gebbink MF: A role for protein misfolding in immunogenicity of biopharmaceuticals. J Biol Chem 2007, 282:2229-2236.
51. Nishimura K, Yoon YH, Kurihara A, Unzai S, Luirink J, Park SY, Tame JR: Role of domains within the autotransporter Hbp/Tsh. Acta Crystallogr D Biol Crystallogr 2010, 66:1295-1300.
52. Kang'ethe W, Bernstein HD: Charge-dependent secretion of an intrinsically disordered protein via the autotransporter pathway. Proc Natl Acad Sci U S A 2013, 110:E4246-E4255.
53. Luirink J, Yu Z, Wagner S, de Gier JW: Biogenesis of inner membrane proteins in Escherichia coli. Biochim Biophys Acta 1817, 2012:965-976.
54. Skillman KM, Barnard TJ, Peterson JH, Ghirlando R, Bernstein HD: Efficient secretion of a folded protein domain by a monomeric bacterial autotransporter. Mol Microbiol 2005, 58:945-958.
55. Andersen P, Woodworth JS: Tuberculosis vaccines-rethinking the current paradigm. Trends Immunol 2014, 35:387-395.
56. Jensen PE: Recent advances in antigen processing and presentation. Nat Immunol 2007, 8:1041-1048.
57. Barlow DJ, Edwards MS, Thornton JM: Continuous and discontinuous protein antigenic determinants. Nature 1986, 322:747-748.
58. Lim KH, Huang H, Pralle A, Park S: Stable, high-affinity streptavidin monomer for protein labeling and monovalent biotin detection. Biotechnol Bioeng 2013, 110:57-67.
59. Nilsson B, Moks T, Jansson B, Abrahmsen L, Elmblad A, Holmgren E, Henrichson C, Jones TA, Uhlen M: A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng 1987, 1:107-113.
60. Lycke N: Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 2012, 12:592-605.
61. Hegazy WA, Xu X, Metelitsa L, Hensel M: Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens. Infect Immun 2012, 80:1193-1202.
62. de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD: Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003, 115:63-73.
63. Casadaban MJ, Cohen SN: Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J Mol Biol 1980, 138:179-207.
64. Soprova Z, Sauri A, van Ulsen P, Tame JR, den Blaauwen T, Jong WS, Luirink J: A conserved aromatic residue in the autochaperone domain of the autotransporter Hbp is critical for initiation of outer membrane translocation. J Biol Chem 2010, 285:38224-38233.
65. Spiess C, Beil A, Ehrmann M: A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell 1999, 97:339-347.
66. DeLisa MP, Tullman D, Georgiou G: Folding quality control in the export of proteins by the bacterial twin-arginine translocation pathway. Proc Natl Acad Sci U S A 2003, 100:6115-6120.
67. Hoiseth SK, Stocker BA: Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981, 291:238-239.
68. Otto BR, van Dooren SJ, Dozois CM, Luirink J, Oudega B: Escherichia coli hemoglobin protease autotransporter contributes to synergistic abscess formation and heme-dependent growth of Bacteroides fragilis. Infect Immun 2002, 70:5-10.
69. van Dooren SJ, Tame JR, Luirink J, Oudega B, Otto BR: Purification of the autotransporter protein Hbp of Escherichia coli. FEMS Microbiol Lett 2001, 205:147-150.
70. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB: Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun 1995, 63:1710-1717.
71. Hashemzadeh-Bonehi L, Mehraein-Ghomi F, Mitsopoulos C, Jacob JP, Hennessey ES, Broome-Smith JK: Importance of using lac rather than ara promoter vectors for modulating the levels of toxic gene products in Escherichia coli. Mol Microbiol 1998, 30:676-678.
72. Wang TT, Tan GS, Hai R, Pica N, Ngai L, Ekiert DC, Wilson IA, Garcia-Sastre A, Moran TM, Palese P: Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A 2010, 107:18979-18984.